Edges in Network
| Network | GSE12093_egf1520 - GSE12093 - SiGN-BN HC+Bootstrap |
| Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
| Node | SHC2 |
| Upstream (Parents) |
|---|
| (<<) DDX21 → SHC2 |
| (<<) EFNB2 → SHC2 |
| (<<) ENO3 → SHC2 |
| (<<) GLTPD1 → SHC2 |
| (<<) GSTK1 → SHC2 |
| (<<) HLA-G → SHC2 |
| (<<) ITGA5 → SHC2 |
| (<<) MAN2A2 → SHC2 |
| (<<) MAP2K1 → SHC2 |
| (<<) MAP3K11 → SHC2 |
| (<<) MLPH → SHC2 |
| (<<) MYL6B → SHC2 |
| (<<) NOTCH1 → SHC2 |
| (<<) PALM → SHC2 |
| (<<) PRKAB1 → SHC2 |
| (<<) RHOA → SHC2 |
| (<<) RNF138 → SHC2 |
| (<<) SOD1 → SHC2 |
| (<<) SQLE → SHC2 |
| (<<) TCEB1 → SHC2 |
| Downstream (Children) |
|---|
| SHC2 → ACAT2 (>>) |
| SHC2 → AVP (>>) |
| SHC2 → FLJ22184 (>>) |
| SHC2 → HIST3H3 (>>) |
| SHC2 → MT1P2 (>>) |
| SHC2 → NRAS (>>) |
| SHC2 → PRKACB (>>) |
| SHC2 → PRKCI (>>) |
| SHC2 → RHBDL1 (>>) |
| SHC2 → ST3GAL1 (>>) |
| SHC2 → STK11 (>>) |
